一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

Ocrelizumab

Ocrelizumab Struktur
637334-45-3
CAS-Nr.
637334-45-3
Englisch Name:
Ocrelizumab
Synonyma:
RG1594;PRO70769;Ocrelizumab;Ocrelizumab (anti-CD20);Research Grade Ocrelizumab;Research Grade Ocrelizumab(DHC90702)
CBNumber:
CB23039319
Summenformel:
C19H16N2O5
Molgewicht:
0
MOL-Datei:
Mol file

Ocrelizumab Eigenschaften

Aggregatzustand
Liquid
Farbe
Colorless to light yellow

Sicherheit

Giftige Stoffe Daten 637334-45-3(Hazardous Substances Data)

Ocrelizumab Chemische Eigenschaften,Einsatz,Produktion Methoden

History

The development of Ocrelizumab, sold under the brand name Ocrevus, starts with rituximab, another monoclonal antibody (MAb) that was developed for the treatment of autoimmune disorders and was approved for the treatment of CD20-positive follicular non-Hodgkin lymphoma in 1994. However, rituximab is a chimeric MAb and is immunogenic in humans, and the manufacturer decided to focus on the similar but fully humanized MAb, ocrelizumab, for multiple sclerosis instead. It was granted approval by the U.S. Food and Drug Administration (FDA) in 2017 as the first treatment indicated for both relapsing and primary progressive forms of multiple sclerosis.Ocrelizumab has also been approved by the European Medicines Agency.

Verwenden

Treatment of rheumatoid arthritis.

Ocrelizumab Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Ocrelizumab Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 40)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
AFINE CHEMICALS LIMITED
+86-571-85134551
info@afinechem.com China 15083 58
Zibo Hangyu Biotechnology Development Co., Ltd
+86-0533-2185556 +8615965530500
nickzhang@hangyubiotech.com China 9946 58
Aladdin Scientific

tp@aladdinsci.com United States 57505 58
NANJING YINGWEN BIOTECHNOLOGY CO LTD
+8613382787392
sales@aeechem.com China 10002 58
Suzhou Genelee Bio-Technology Co., Ltd 86-17715515539 17715515539
James@geneleebio.com China 61 58
Wuhan Sunrise Technology Development Co., Ltd. 27-027-83314682 13554138826
whsrtech@vip.163.com China 102 62
BOC Sciences 1-631-485-4226; 16314854226
info@bocsci.com United States 9920 65
Dalian Meilun Biotech Co., Ltd. 0411-62910999 13889544652
sales@meilune.com China 4794 58
Nanjing Sunlida Biological Technology Co., Ltd. 025-57798810 18652991625
sales@sunlidabio.com China 3239 55
Shanghai EFE Biological Technology Co., Ltd. 021-65675885 18964387627
info@efebio.com China 9804 58

  • Ocrelizumab
  • Research Grade Ocrelizumab(DHC90702)
  • Ocrelizumab (anti-CD20)
  • Research Grade Ocrelizumab
  • PRO70769
  • RG1594
  • 637334-45-3
Copyright 2019 ? ChemicalBook. All rights reserved
文昌市| 象州县| 阿合奇县| 长兴县| 通州市| 峨山| 平果县| 醴陵市| 沧源| 大同县| 江北区| 阳曲县| 无为县| 开江县| 襄垣县| 衡水市| 玉山县| 江北区| 平阴县| 巴林右旗| 望都县| 平潭县| 项城市| 赤水市| 曲麻莱县| 黑河市| 池州市| 积石山| 陆良县| 渭南市| 五家渠市| 苍溪县| 涪陵区| 灌南县| 玛纳斯县| 遵义县| 溧阳市| 兴安盟| 五台县| 皋兰县| 晴隆县|